Evidence map›Paper›PMID 35559237›Full record

ArticleFrontiers in pharmacology2022

Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs for Psoriatic Arthritis: Findings and Implications From a Patient Centered Longitudinal Study in Brazil.

Ronaldo José Faria, Francisca Janiclecia Rezende Cordeiro, Jéssica Barreto Ribeiro Dos Santos, Juliana Alvares-Teodoro, Augusto Afonso Guerra Júnior, Francisco de Assis Acurcio, Michael Ruberson Ribeiro da Silva

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ronaldo José FariaPharmaceutical Services Graduate Program, Federal University of Espírito Santo, Alegre, Brazil.
Francisca Janiclecia Rezende CordeiroHealth Assessment, Technology, and Economy Group, Federal University of Espírito Santo, Alegre, Brazil.
Jéssica Barreto Ribeiro Dos SantosPharmaceutical Services Graduate Program, Federal University of Espírito Santo, Alegre, Brazil.
Juliana Alvares-TeodoroDepartment of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Augusto Afonso Guerra JúniorDepartment of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Francisco de Assis AcurcioDepartment of Social Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Michael Ruberson Ribeiro da SilvaPharmaceutical Services Graduate Program, Federal University of Espírito Santo, Alegre, Brazil.
Universidade Federal do Espírito Santo · BRUniversidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antirheumatic agentsdrug costsmedication adherencepharmacoepidemiologypsoriatic arthritis

Identifiers

PMID35559237
PMCPMC9086188
OpenAlexW4224602508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.